NEW YORK, Sept. 27 - Sequitur and Discovery Genomics have partnered to screen antisense compounds and study gene function in zebra fish, according to both companies. 

The multiyear agreement calls for Sequitur to use its antisense compounds and high throughput gene expression analysis. Discovery Genomics will bring to the table its functional genomics experience with the zebra fish model. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.